C50 Cancer de mama
Conditions
Interventions
None listed
Sponsors
INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Premenopausal or postmenopausal patients with histologically proven primary breast cancer. Estrogen and progesterone receptor status must be known by immunohistochemistry, before randomization, and both must be negative, which is defined as < 10% of the tumor cells positive by immunohistochemical evaluation.
Exclusion criteria
Exclusion criteria: Patients with T4 carcinoma with ulceration of skin, infiltration of skin. Patients with bilateral malignancies (except in situ carcinoma), or with a suspicious mass in the opposite breast, tmless that mass has been proven by biopsy to be benign.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| not contemplated NAME OF THE RESULT: not contemplated PERIOD OF TIME WHERE TE MEASUREMENT WILL BE CONDUCTED AND WHICH WILL ALLOW OBTAINING THE PRIMARY RESULT: not contemplated | — |
Secondary
| Measure | Time frame |
|---|---|
| not contemplated NAME OF THE RESULT: not contemplated PERIOD OF TIME WHERE TE MEASUREMENT WILL BE CONDUCTED AND WHICH WILL ALLOW OBTAINING THE PRIMARY RESULT: not contemplated;not contemplated NAME OF THE RESULT: not contemplated PERIOD OF TIME WHERE TE MEASUREMENT WILL BE CONDUCTED AND WHICH WILL ALLOW OBTAINING THE PRIMARY RESULT: not contemplated | — |
Countries
Peru
Outcome results
None listed